Kezar Life Sciences Return on Net Operating Assets Trends

Kezar Life Sciences, Inc. (KZR)

6.19 +0.04 (+0.65%) USD | NASDAQ | Jan 21, 16:00

6.17 -0.02 (-0.32%) Pre-Market: 20:00

View Return on Net Operating Assets for KZR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

Artiva Biotherapeutics, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	Upgrade
Palatin Technologies, Inc.	Upgrade
Theriva Biologics, Inc.	Upgrade
Oragenics, Inc.	Upgrade